企業プロフィール
Cryo-Cell 株価・ニュース・カタリスト
- ティッカー:
- CCEL
- 取引所:
- AMEX
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.56 USD (+9.09%)
終値
最終更新: 2026年8月21日
27.3M USD
時価総額
株価変動の要因
As of Aug 21, 2026, CCEL closed up 9.09% at $4.56. No new same-company headline was identified in the current news window.
企業概要
Cord Blood and Tissue Banking
Cryo-Cell International, founded in 1989, is one of the earliest private cord blood banks. Together with affiliated organizations, it has stored more than 250,000 cord blood and cord tissue samples, generating revenue from processing and long-term storage services.
Private Family Banking
Cryo-Cell’s core service allows families to preserve newborn cord blood and cord tissue for potential future medical use. Revenue includes initial collection and processing fees as well as recurring long-term storage fees.
Public Cord Blood Banking
Cryo-Cell also operates a public banking program with Duke University and maintains a donation site at Cedars-Sinai Medical Center. The public bank has supported more than 900 transplants.
Quality Systems and Processing Technology
The company’s facilities are FDA-registered, operate under cGMP and cGTP standards, and hold multiple state licenses and quality accreditations, including AABB and FACT. Cryo-Cell also holds exclusive rights to PrepaCyte-CB, its advanced cord blood processing technology.
今後のカタリスト
- Cryo-Cell’s catalysts are cord-blood banking, fertility services, and steady recurring consumer-health demand. The company moves more on operations than on binary events.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。